 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
From 8th Feb to 14th March
Any or all articles are available on request from vivisectionkills@hotmail.com
· “Diabetes Heart Treatments May Cause Harm.”
· “Cataracts From Antidepressants? Study: 22,000 U.S. Cataract Cases May Be Due to SSRI Antidepressants.”
· Pfizer shares fall as cancer drug fails
· “Roche’s Prostate Cancer Drug Marks a Failure in a Clinical Trial”
· “Off-label prescriptions lucrative but dangerous.”
· “Novartis Heart, Diabetes Drugs Fail to Prevent Disease in Study.”
· “Plavix is given FDA's strongest warning.”
· “Pfizer Says Two Cancer Drugs Fail in Clinical Trials”
· “FDA Medwatch. February 2010 Drug Safety Labeling Changes” - 24 boxed warnings added
· Health threat of drug promotion to elderly in care homes
· Alzheimer’s drug fails
· “Roche, Biogen suspends arthritis drug after deaths”
· “Astra's colon cancer drug fails test.”
· Astra Zeneca shares crash as drugs fail
· Newer epilepsy drugs more dangerous for children
· Popular drugs (Prozac, painkillers) can lead to a fatal heart attack
· Avandia linked to heart disorders
· Court links Roche's Accutane to bowel disease.
· “Hormone replacement tied to lung cancer risk”
· “Avastin fails stomach-cancer trial”
· “Serious Side Effects Seen with Novel Nephropathy Drug”
· “Chemicals suspected in breast cancer, US experts want tests.”
· “Did Popular Birth Control Drug Cause Death?”
· “My limbs burnt. This has ruined my life” (ADR)
· “Merck’s HIV treatment fails in phase III”
· “FDA aims to limit use of LABA asthma meds”
· FDA Medwatch. MedWatch January 2010 Drug Safety Labeling Changes.
“This posting includes 36 drug products with safety labelling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS,PATIENT PACKAGE INSERT, and MEDICATION GUIDE.”
· FDA issue boxed warning to Exjade.
· Is asthma drug Advair linked to asthma deaths?
· “HRT doubles heart disease risk in two years”
· Cholesterol drugs increase diabetes risk
· Drugs can make tumours grow faster
· “FDA rejects Glaxo-XenoPort restless-leg drug.”
· “Fracture risk tied to diabetes drug.”
· “'Dangerous' cold remedies should be taken off the shelves”
· “FDA Staff Raises Concerns About NHL Drug.”
· “Merck Pays $12 Million in Lawyer Fees to End Vioxx Suits.”
· BMJ Editorial: “Avoid coprescribing paroxetine and tamoxifen in women with breast cancer”
· “Australian Court: Vioxx Doubled Heart Attack Risk”
· “Popular antidepressant interferes with cancer drug.”
· “Merck to Change Safety Procedures, Pay Fees to End Vioxx Suits.”
· “Estrogen hormone therapy linked to asthma in study.”
Related Articles:
